Juvenile Myositis clinical trials at UCSF
1 research study open to eligible people
Juvenile myositis is a rare disease that causes muscle weakness and skin rashes in children. UCSF is running studies that test new medicines for safety and effect in children with active disease. UCSF is also collecting blood and muscle data to learn how treatments change the disease.
Showing trials for
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
open to eligible people ages 6-75
RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
San Francisco, California and other locations
Our lead scientists for Juvenile Myositis research studies include Susan Kim.
Last updated: